[1]崔雅婷,王俊斐,徐彩花,等.全球卫生技术评估研究热点与发展趋势[J].卫生经济研究,2026,43(03):6-10.
　CUI Yating,WANG Junfei,XU Caihua,et al.Analysis of Research Hotspots and Development Trends in Health Technology Assessment[J].Journal Press of Health Economics Research,2026,43(03):6-10.
点击复制

全球卫生技术评估研究热点与发展趋势

卫生经济研究[ISSN:1004-7778/CN:33-1056/F]

卷:
43
期数:
2026年03期
页码:
6-10
栏目:
理论研究
出版日期:
2026-03-03

文章信息/Info

Title:
Analysis of Research Hotspots and Development Trends in Health Technology Assessment
作者:
崔雅婷1; 王俊斐1; 徐彩花1; 张明悦1; 郑卿勇1; 许建国1; 周泳佳1; 2; 肖 月3; 田金徽1
1.兰州大学基础医学院循证医学中心，甘肃 兰州 730000
2.甘肃中医药大学护理学院，甘肃 兰州 730000
3.国家卫生健康委卫生发展研究中心暨国家药品与卫生技术综合评估中心，北京 100191
Author(s):
CUI Yating;  WANG Junfei;  XU Caihua;  ZHANG Mingyue;  ZHENG Qingyong;  XU Jianguo;  ZHOU Yongjia;  XIAO Yue;  TIAN Jinhui
Evidence-based Medicine Center, School of Basic Medical Sciences, Lanzhou University, Lanzhou Gansu 730000, China
关键词:
卫生技术评估; 文献计量分析; 研究现状; 发展趋势
Keywords:
health technology assessment;  bibliometric analysis;  research status;  development trends
分类号:
R19
文献标志码:
A
摘要:
目的：探讨全球卫生技术评估领域的研究热点、发展趋势与挑战，为学术研究和政策制定提供科学依据。方法：采用文献计量学方法，基于Web of Science数据库检索卫生技术评估相关文献，利用VOSviewer和CiteSpace软件分析关键词共现网络，揭示研究热点演变。结果：全球卫生技术评估研究呈现显著增长趋势，2005年以后年发文量显著增长，研究热点涵盖生物医学技术评估、成本效益、生活质量等关键词，聚焦人工智能、个性化医疗等新兴技术。结论：卫生技术评估逐步从单一临床效果扩展为多维度综合评估，未来研究将聚焦新兴技术、跨学科支持及伦理公平问题；为应对技术变革，卫生技术评估需转向动态评估并加强国际合作。
Abstract:
Objective To explore the research hotspots, development trends, and challenges in the field of health technology assessment (HTA), and to provide scientific evidence for academic research and policy-making. Methods Using bibliometric methods, relevant literature on HTA was retrieved from the Web of Science database. VOSviewer and CiteSpace software were used to examine keyword and author co-occurrence networks, revealing the evolution of research hotspots. Results Research in the field of HTA had shown a significant upward trend, with a marked increase in annual publications since 2005. Research hotspots included digital health, cost-effectiveness, and quality of life, with growing attention to emerging technologies such as artificial intelligence and personalized medicine. Conclusion HTA is progressively expanding from single-dimensional clinical effectiveness to multidimensional comprehensive assessment. Future research is expected to emphasize emerging technologies, interdisciplinary support, and issues of ethics and equity. In response to rapid technological advancements, HTA should shift toward dynamic evaluation and strengthen international collaboration.

参考文献/References:

[1] 赵博琛，谢薇，张子洵，等.卫生技术评估的概念、实践与展望[J].健康体检与管理，2024，5（03）：279-286.
[2] 吴雪，景城阳，施兰君，等.国内外卫生技术评估方法指南的系统评价[J].中国循证医学杂志，2024，24（09）：1021-1029.
[3] Angelis A, Lange A, Kanavos P. Using health technology assessment to assess the value of new medicines: results of a systematic review and expert consultation across eight European countries[J]. Eur J Health Econ, 2018, 19(01): 123-152.
[4] Stenberg K, Hanssen O, Bertram M, et al. Guide posts for investment in primary health care and projected resource needs in 67 low-income and middle-income countries: a modelling study[J].Lancet Glob Health, 2019, 7(11): 1500-1510.
[5] 杨燕，唐密，何江江.医保药品目录调整视角下的卫生技术评估多维度决策框架研究[J].中国卫生经济，2023，42（11）：28-32.
[6] 刘梦娜，吴斌，艾丹丹，等.药物快速卫生技术评估方法学研究——以抗肿瘤用药为例[J].中国药房，2022，33（11）：1386-1391.
[7] Nemzoff C, Shah H A, Heupink L F, et al. Adaptive Health Technology Assessment: a scoping review of methods[J]. Value Health, 2023, 26(10): 1549-1557.
[8] Pichler F B, Boysen M, Mittmann N, et al. Lifecycle HTA: promising applications and a framework for implementation. An HTAi Global Policy Forum Task Force report[J]. Int J Technol Assess Health Care, 2024, 40(01): 50.
[9] Garrison L P, Jiao B, Dabbous O. Gene therapy may not be as expensive as people think: challenges in assessing the value of single and short-term therapies[J]. J Manag Care Spec Pharm, 2021, 27(05): 674-681.
[10] A bibliometric analysis and visualization of current research trends in Chinese medicine for osteosarcoma[J]. Chin J Integr Med, 2022， 28(05): 445-452.
[11] 张明悦，徐彩花，石学睿，等.基于2022年高等教育（本科）国家级教学成果奖的实证研究[J].中国医药导刊，2023，25（06）：654-660.
[12] 徐彩花，张明悦，周泳佳，等.对分课堂在国内医学教育中应用的可视化分析[J].基础医学教育，2024（05）：375-382.
[13] 郑卿勇，段丹，祝清爽，等.国内外大学生艾滋病研究热点与前沿趋势[J].现代预防医学，2022，49（08）：1506-1513.
[14] 陈一欧，宝颖，马华峥，等.基因编辑技术及其在中国的研究发展[J].遗传，2018，40（10）：900-915.
[15] 李佳晋，黄天笑，孙育杰，等.HTA在发达国家医保体系中的发展及对我国的启示[J].中国医疗保险，2024（01）：100-110.
[16] 江英婵，张勇勤，张琦，等.数字健康技术在缓解围生期女性负性情绪中应用的研究进展[J].护理研究，2024，38（17）：3087-3093.
[17] 北京协和医院罕见病多学科协作组，中国罕见病联盟.多准则决策分析应用于罕见病药品临床综合评价的专家共识（2022）[J].协和医学杂志，2022，13（02）：235-254.
[18] 颜芬芬，韩宝江，王道雄.基于真实世界数据的止血材料使用评价研究[J].中国医疗设备，2023，38（12）：131-136.
[19] 刘晶.基于中医药特色的三级公立中医医院高质量发展评价指标体系研究[D].北京：中国中医科学院，2023.
[20] 李帅.生态环境监测技术在职业卫生技术服务中的应用研究[J].生态与资源，2024（12）：81-83.
[21] Basu A, Winn A N, Johnson K M, et al. Gene therapy versus common care for eligible individuals with sickle cell disease in the United States: a cost-effectiveness analysis[J]. Ann Intern Med, 2024, 177(02): 155-164.
[22] Baltussen R, Marsh K, Thokala P, et al. Multicriteria decision analysis to support health technology assessment agencies: benefits, limitations, and the way forward[J]. Value Health, 2019, 22(11): 1283-1288.
[23] 赵锐，石秀园，钟雪然，等.基于卫生技术评估构建医学人工智能技术临床应用评估路径的探讨[J].中国卫生政策研究，2022，15（02）：78-82.
[24] 姚嘉奇，周挺，管欣，等.英国NICE卫生技术评估介绍及对我国医保目录动态调整的启示[J].中国循证医学杂志，2018，18（09）：984-989.
[25] 邢质聪，孙福东，薛青霞，等.4种静脉铁剂治疗缺铁性贫血的快速卫生技术评估[J].药物流行病学杂志，2024，33（09）：1030-1043.
[26] 薛迪.卫生技术创新中的社会伦理思考：以“免疫艾滋病基因编辑婴儿”为例[J].中国卫生资源，2019，22（01）：66-67.

相似文献/References:

[1]谭华伟,颜维华,刘 宪,等.新医改对公立医院补偿机制研究的影响分析[J].卫生经济研究,2016,(04):14.
[2]黄 理,路 云,段承阿鑫.卫生技术评估在高值医用耗材供应保障中的应用价值及其实现[J].卫生经济研究,2018,(10):10.
　HUANG Li,LU Yun,DUAN Cheng-a-xin.The Application Value and Its Realization of Health Technology Assessment in the Supply Security of High-value Medical Consumables[J].Journal Press of Health Economics Research,2018,(03):10.
[3]金春林,王海银,孙 辉,等.价值医疗的概念、实践及其实现路径[J].卫生经济研究,2019,(02):6.
　JIN Chun-lin,WANG Hai-yin,SUN Hui,et al.The Concept, Progress and Practice Path of Value-based healthcare[J].Journal Press of Health Economics Research,2019,(03):6.
[4]傅 卫,赵 琨.中国卫生技术评估的发展与挑战[J].卫生经济研究,2019,(03):3.
　FU Wei,ZHAO Kun.Development and Challenges of China's Health Technology Assessment[J].Journal Press of Health Economics Research,2019,(03):3.
[5]张 宸,金秋晨,陈永法.儿童药卫生技术评估的特殊性——以英国NICE儿童药评估为例[J].卫生经济研究,2021,38(11):51.
　ZHANG Chen,JIN Qiu-chen,CHEN Yong-fa.Particularity of Health Technology Assessment for Children's Drug——Taking NICE Children's Drug Assessment as an Example[J].Journal Press of Health Economics Research,2021,38(03):51.
[6]陈 娟,慕华桥,彭 丽,等.基于文献计量的DRG与DIP实施现状及效果比较[J].卫生经济研究,2022,39(12):45.
　CHEN Juan,MU Huaqiao,PENG Li,et al.A Comparative Study of the Status and Effects of DRG and DIP Implementation based on Bibliometric[J].Journal Press of Health Economics Research,2022,39(03):45.
[7]金秋晨,张 宸,陈永法.抗肿瘤药物联合疗法价值归因探索[J].卫生经济研究,2023,40(10):74.
　JIN Qiuchen,ZHANG Chen,CHEN Yongfa.Study on the Value Attribution of Antitumor Drug Combination Therapy[J].Journal Press of Health Economics Research,2023,40(03):74.
[8]郑王彪,郑 超,孙 强.医保药品目录动态调整的国际经验与启示[J].卫生经济研究,2023,40(12):62.
　ZHENG Wangbiao,ZHENG Chao,SUN Qiang.International Experience and Enlightenment on the Dynamic Adjustment of Medical Insurance Drug Catalog[J].Journal Press of Health Economics Research,2023,40(03):62.
[9]杨婷婷,薛允莲,吴伟旋,等.高值医用耗材评价的难点分析与方法优化 ——基于多维度分析[J].卫生经济研究,2025,42(11):54.
　YANG Tingting,XUE Yunlian,WU Weixuan,et al.Analysis of Challenges and Optimization of Methods in the Evaluation of High-Value Medical Consumables ——Based on a Multi-Dimensional Analysis[J].Journal Press of Health Economics Research,2025,42(03):54.
[10]骆依静,许 军,陈星伟,等.药品价值评价的全球趋势与中国实践研究[J].卫生经济研究,2026,43(02):47.
　LUO Yijing,XU Jun,CHEN Xingwei,et al.Research on Global Trends and Chinese Practice in Drug Value Assessment[J].Journal Press of Health Economics Research,2026,43(03):47.

更新日期/Last Update: 2026-03-03